Nanostics
Edmonton
About Nanostics
Nanostics is a developer of diagnostics tests intended to diagnose aggressive prostate cancer.The company's technology combines a sensitive extracellular vesicle detection platform with advanced machine learning to diagnose disease and predict clinically significant prostate cancer from a simple blood test, enabling healthcare professionals to provide clarity to patients about their health by enabling better diagnosis and improving health care decisions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $5.0M
- Last round: Grant (Jun 2025)
- Website: nanosticsdx.com
- Phone: 1-800-672-2027
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/nanostics-87223 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.